These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3081399)

  • 1. Role of endogenous gastric prostanoids in the pathogenesis and therapy of duodenal ulcer.
    Rachmilewitz D; Ligumsky M; Fich A; Goldin E; Eliakim A; Karmeli F
    Gastroenterology; 1986 Apr; 90(4):963-9. PubMed ID: 3081399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of misoprostol and ranitidine in the prevention of duodenal ulcer relapse and its correlation with endogenous gastric prostanoid synthesis.
    Goldin E; Karmeli F; Rachmilewitz D
    Aliment Pharmacol Ther; 1991 Apr; 5(2):173-80. PubMed ID: 1909584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostanoid synthesis by cultured gastric and duodenal mucosa: Possible role in the pathogenesis of duodenal ulcer.
    Sharon P; Cohen F; Zifroni A; Karmeli F; Ligumsky M; Rachmilewitz D
    Scand J Gastroenterol; 1983 Nov; 18(8):1045-9. PubMed ID: 6584967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active smoking depresses prostaglandin synthesis in human gastric mucosa.
    Quimby GF; Bonnice CA; Burstein SH; Eastwood GL
    Ann Intern Med; 1986 May; 104(5):616-9. PubMed ID: 3457547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cimetidine on human gastric and duodenal prostanoid synthesis.
    Branski D; Sharon P; Karmeli F; Rachmilewitz D
    Scand J Gastroenterol; 1984 Jun; 19(4):457-60. PubMed ID: 6589742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patients.
    Lezoche E; Vagni V; D'Alessandro MD; Mariani P; Carlei F; Lomanto D; Nardovino M; Martelli A; Speranza V
    Drugs Exp Clin Res; 1987; 13(10):655-8. PubMed ID: 2892658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous measurement of in vitro gastroduodenal prostaglandin E2 synthesis and degradation in peptic ulcer disease.
    Crampton JR; Gibbons LC; Rees WD
    Scand J Gastroenterol; 1987 May; 22(4):425-30. PubMed ID: 3474773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic antral gastritis in duodenal ulcer. Natural history and treatment with prostaglandin E1.
    Hui WM; Lam SK; Ho J; Ng MM; Lui I; Lai CL; Lok AS; Lau WY; Poon GP; Choi S
    Gastroenterology; 1986 Nov; 91(5):1095-101. PubMed ID: 3093305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 and F2 alpha levels in the duodenal and antral mucosa of non-ulcer dyspeptic and duodenal ulcer patients.
    Parodi MC; Marugo M; Ciancamerla G; Santucci R; Fazzuoli L
    Hepatogastroenterology; 1990 Apr; 37(2):208-11. PubMed ID: 2341116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mucus and prostaglandins in the gastric mucosal protective actions of sucralfate against ethanol-induced injury in the rat.
    Quadros E; Ramsamooj E; Wilson DE
    Am J Med; 1987 Sep; 83(3B):19-23. PubMed ID: 3477959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients.
    Rachmilewitz D; Karmeli F; Eliakim R; Stalnikowicz R; Ackerman Z; Amir G; Stamler JS
    Gut; 1994 Oct; 35(10):1394-7. PubMed ID: 7525417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.
    Kummer AF; Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger SA
    Gut; 1992 Feb; 33(2):175-8. PubMed ID: 1541412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nizatidine versus ranitidine on gastric intraluminal prostaglandin release in duodenal ulcer patients.
    Silecchia G; Spaziani E; Guarino E; Neri T; Grasso E; Mariani P; Materia A; Genco A; Basso N
    Scand J Gastroenterol Suppl; 1994; 206():8-13. PubMed ID: 7863255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effective drugs and less effective drugs in the treatment of duodenal ulcer].
    Ligny G; Van Cauter J
    Acta Gastroenterol Belg; 1984; 47(6):569-75. PubMed ID: 6100349
    [No Abstract]   [Full Text] [Related]  

  • 16. Antral release of gastrin and somatostatin in duodenal ulcer and control subjects.
    Harty RF; Maico DG; McGuigan JE
    Gut; 1986 Jun; 27(6):652-8. PubMed ID: 2873083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of misoprostol and cimetidine on gastric cell turnover.
    Fich A; Arber N; Sestieri M; Zajicek G; Rachmilewitz D
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):133S-135S. PubMed ID: 3932045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate protection of human gastric mucosa against acute ethanol injury.
    Cohen MM; Bowdler R; Gervais P; Morris GP; Wang HR
    Gastroenterology; 1989 Feb; 96(2 Pt 1):292-8. PubMed ID: 2642875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcer-healing drugs and endogenous prostaglandins.
    Guslandi M
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):398-402. PubMed ID: 2864318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal and antral mucosal prostaglandin E2 synthesis in a study of normal subjects and all stages of duodenal ulcer disease treated by H2 receptor antagonists.
    Pugh S; Williams SE; Lewin MR; Ishaque M; Barton TP; Bose K; Bardhan KD; Clark CG
    Gut; 1989 Feb; 30(2):161-5. PubMed ID: 2564833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.